Literature DB >> 9647219

Induction of oral tolerance in TGF-beta 1 null mice.

K S Barone1, D D Tolarova, I Ormsby, T Doetschman, J G Michael.   

Abstract

Previous studies have suggested that oral tolerance induction by low doses of Ag is mediated by inhibitory cytokines, particularly TGF-beta 1. To examine the roles of TGF-beta 1 and other inhibitory cytokines in the induction of oral tolerance, TGF-beta 1 null mice and controls were gavaged with 10 to 20 mg (high dose) or 1 mg (low dose) of OVA for 3 days. After immunization with OVA, the in vitro proliferative response of OVA-specific popliteal lymph node cells was assessed. Lymphocytes from all TGF-beta 1 null mice fed high doses of OVA exhibited highly significant suppression compared with controls. A weaker, but still significant, suppression was observed in lymphocytes from the majority of TGF-beta 1 null mice fed low doses of OVA. In addition, supernatants from these lymphocytes exhibited lower levels of IL-4, IL-10, and IFN-gamma than those from water-fed control animals. These results indicate that while TGF-beta 1 may play a role in suppression, inhibitory cytokines are not the exclusive mechanism by which low dose oral tolerance is induced.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647219

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Oral tolerance of food.

Authors:  Steve Stanley
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

2.  Effect of in vivo administration of anti-CTLA-4 monoclonal antibody and IL-12 on the induction of low-dose oral tolerance.

Authors:  K S Barone; B Herms; L Karlosky; S Murray; J Qualls
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

3.  Oral tolerance in the absence of naturally occurring Tregs.

Authors:  Daniel Mucida; Nino Kutchukhidze; Agustin Erazo; Momtchilo Russo; Juan J Lafaille; Maria A Curotto de Lafaille
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

4.  Role of CTLA-4, IL-18 and IL-10 on the Induction of Low Dose Oral Tolerance.

Authors:  Kathleen Siobhan Barone; Rachael Burns; Stephanie Horton; Armando Retana; Lindsey Jackson Meredith Wall; Tifany Nolan
Journal:  J Ky Acad Sci       Date:  2008-03-01

Review 5.  Animal models of food allergy: opportunities and barriers.

Authors:  Scott McClain; Gary A Bannon
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

Review 6.  Vaccination strategies for mucosal immune responses.

Authors:  P L Ogra; H Faden; R C Welliver
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

7.  TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.

Authors:  Ramireddy Bommireddy; Ilona Ormsby; Moying Yin; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

Review 8.  Mechanism of oral tolerance induction to therapeutic proteins.

Authors:  Xiaomei Wang; Alexandra Sherman; Gongxian Liao; Kam W Leong; Henry Daniell; Cox Terhorst; Roland W Herzog
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

Review 9.  Oral tolerance.

Authors:  Henry Yim Wu; Howard L Weiner
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 10.  An Overview of Challenges Limiting the Design of Protective Mucosal Vaccines for Finfish.

Authors:  Hetron Mweemba Munang'andu; Stephen Mutoloki; Øystein Evensen
Journal:  Front Immunol       Date:  2015-10-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.